Skip to main content

Levetiracetam

NDC 51672-4136 · Sun Pharmaceutical Industries, Inc.

Generic nameLevetiracetam
Dosage formSOLUTION
RouteORAL
Active ingredient(s)LEVETIRACETAM
Strength100 mg/mL
Pharmacologic classDecreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA

Packages

51672-4136-0 — 3785 mL in 1 BOTTLE (51672-4136-0)

51672-4136-7 — 100 mL in 1 BOTTLE (51672-4136-7)

51672-4136-9 — 473 mL in 1 BOTTLE (51672-4136-9)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50474-002 — levetiracetam, 50474-594 — levetiracetam, 50474-595 — levetiracetam, 50474-596 — levetiracetam, 50474-597 — levetiracetam, 50474-598 — levetiracetam, 50474-599 — levetiracetam, 51079-821 — levetiracetam, 51224-013 — levetiracetam, 51655-325 — Levetiracetam, 53041-660 — Levetiracetam, 55111-181 — Levetiracetam, 55111-182 — Levetiracetam, 55111-183 — Levetiracetam, 55111-248 — Levetiracetam, 55150-177 — Levetiracetam, 55150-246 — Levetiracetam in sodium chloride, 55150-247 — Levetiracetam in sodium chloride, 55150-248 — Levetiracetam in sodium chloride, 55154-3367 — Levetiracetam, +277 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels